Jennifer A Frontera1, Randall Starling2, Sung-Min Cho3, Amy S Nowacki4, Ken Uchino3, M Shazam Hussain3, Maria Mountis2, Nader Moazami2. 1. Department of Neurology, New York University, New York, New York. Electronic address: frontej@ccf.org. 2. Kaufman Center for Heart Failure and Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio. 3. Department of Neurology, New York University, New York, New York. 4. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Abstract
BACKGROUND: Stroke is a major cause of mortality after left ventricular assist device (LVAD) placement. METHODS: Prospectively collected data of patients with HeartMate II (n = 332) and HeartWare (n = 70) LVADs from October 21, 2004, to May 19, 2015, were reviewed. Predictors of early (during index hospitalization) and late (post-discharge) ischemic and hemorrhagic stroke and association of stroke subtypes with mortality were assessed. RESULTS: Of 402 patients, 83 strokes occurred in 69 patients (17%; 0.14 events per patient-year [EPPY]): early ischemic stroke in 18/402 (4%; 0.03 EPPY), early hemorrhagic stroke in 11/402 (3%; 0.02 EPPY), late ischemic stroke in 25/402 (6%; 0.04 EPPY) and late hemorrhagic stroke in 29/402 (7%; 0.05 EPPY). Risk of stroke and death among patients with stroke was bimodal with highest risks immediately post-implant and increasing again 9-12 months later. Risk of death declined over time in patients without stroke. Modifiable stroke risk factors varied according to timing and stroke type, including tobacco use, bacteremia, pump thrombosis, pump infection, and hypertension (all p < 0.05). In multivariable analysis, early hemorrhagic stroke (adjusted odds ratio [aOR] 4.3, 95% confidence interval [CI] 1.0-17.8, p = 0.04), late ischemic stroke (aOR 3.2, 95% CI 1.1-9.0, p = 0.03), and late hemorrhagic stroke (aOR 3.7, 95% CI 1.5-9.2, p = 0.005) predicted death, whereas early ischemic stroke did not. CONCLUSIONS: Stroke is a leading cause and predictor of death in patients with LVADs. Risk of stroke and death among patients with stroke is bimodal, with highest risk at time of implant and increasing risk again after 9-12 months. Management of modifiable risk factors may reduce stroke and mortality rates.
BACKGROUND:Stroke is a major cause of mortality after left ventricular assist device (LVAD) placement. METHODS: Prospectively collected data of patients with HeartMate II (n = 332) and HeartWare (n = 70) LVADs from October 21, 2004, to May 19, 2015, were reviewed. Predictors of early (during index hospitalization) and late (post-discharge) ischemic and hemorrhagic stroke and association of stroke subtypes with mortality were assessed. RESULTS: Of 402 patients, 83 strokes occurred in 69 patients (17%; 0.14 events per patient-year [EPPY]): early ischemic stroke in 18/402 (4%; 0.03 EPPY), early hemorrhagic stroke in 11/402 (3%; 0.02 EPPY), late ischemic stroke in 25/402 (6%; 0.04 EPPY) and late hemorrhagic stroke in 29/402 (7%; 0.05 EPPY). Risk of stroke and death among patients with stroke was bimodal with highest risks immediately post-implant and increasing again 9-12 months later. Risk of death declined over time in patients without stroke. Modifiable stroke risk factors varied according to timing and stroke type, including tobacco use, bacteremia, pump thrombosis, pump infection, and hypertension (all p < 0.05). In multivariable analysis, early hemorrhagic stroke (adjusted odds ratio [aOR] 4.3, 95% confidence interval [CI] 1.0-17.8, p = 0.04), late ischemic stroke (aOR 3.2, 95% CI 1.1-9.0, p = 0.03), and late hemorrhagic stroke (aOR 3.7, 95% CI 1.5-9.2, p = 0.005) predicted death, whereas early ischemic stroke did not. CONCLUSIONS:Stroke is a leading cause and predictor of death in patients with LVADs. Risk of stroke and death among patients with stroke is bimodal, with highest risk at time of implant and increasing risk again after 9-12 months. Management of modifiable risk factors may reduce stroke and mortality rates.
Authors: Martin Groß; Marcus Pohl; Oliver Summ; Peter Young; Martin Winterholler; Anette Weigel; Rainer Röhrig Journal: Nervenarzt Date: 2019-10 Impact factor: 1.214
Authors: Marykay A Pavol; Joshua Z Willey; Ying Wei; Melana Yuzefpolskaya; Randolph S Marshall; Philip J Marascalco; Jason Harwood; Ronald M Lazar Journal: Gen Thorac Cardiovasc Surg Date: 2018-05-23
Authors: Kara R Melmed; Konrad H Schlick; Brenda Rinsky; Oana M Dumitrascu; Oksana Volod; Mani Nezhad; Matthew M Padrick; Carmelita Runyan; Francisco A Arabia; Jaime D Moriguchi; Patrick D Lyden; Shlee S Song Journal: J Neuroimaging Date: 2020-02-10 Impact factor: 2.486
Authors: Christopher A Wrobel; Mark H Drazner; Colby R Ayers; David D Pham; Ricardo M La Hoz; Justin L Grodin; Sonia Garg; Pradeep P A Mammen; Robert M Morlend; Faris Araj; Alpesh A Amin; William K Cornwell; Jennifer T Thibodeau Journal: J Investig Med Date: 2019-01-29 Impact factor: 2.895
Authors: Muhammad Shahreyar; Tamunoinemi Bob-Manuel; Rami N Khouzam; Mohammad W Bashir; Samian Sulaiman; Oluwaseun Akinseye; Arindam Sharma; April Carter; Samuel Latham; Sanjay Bhandari; Arshad Jahangir Journal: Ann Transl Med Date: 2018-01